Overview

A Study of CFI-400945 With or Without Azacitidine or Decitabine in Patients With AML, MDS or CMML

Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of an investigational drug called CFI-400945 alone and in combination with azacitidine or decitabine
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Treadwell Therapeutics, Inc
Treatments:
Azacitidine
Decitabine